Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro side effects within the first day or two after their initial injection, with nausea being the most commonly reported. For many, symptoms are mild, peak around 24–72 hours post-dose, and settle within a week. That said, how soon side effects arrive (and how pronounced they feel) varies considerably from person to person, and often changes each time the dose increases. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before treatment begins and remains involved throughout, which matters a great deal when side effects are part of the picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the evening after your first Mounjaro injection. You feel fine initially, then a wave of mild nausea arrives sometime in the night. For most people who experience it, that is roughly the sequence. The most common Mounjaro side effects (nausea, loose stools, constipation, reflux and burping) tend to arrive within the first one to two days and are driven largely by tirzepatide's effect on gastric emptying: food moves through the stomach more slowly, which is partly what reduces appetite, but which also unsettles the gut while the body adjusts.
The NHS tirzepatide medicines page notes these effects are generally most noticeable when you start treatment or increase your dose. If you are wondering how soon Mounjaro side effects typically appear, most people find the sharpest discomfort passes within three to five days. Eating smaller portions, avoiding fatty or spicy food in the first few days, and staying well hydrated all seem to help, though your prescriber and the Patient Information Leaflet are the right places to get guidance tailored to you.
It is also worth knowing that plenty of people experience very little at the 2.5mg starting dose. The starter dose exists primarily to let your system adjust, so a gentle first few weeks is genuinely common. What catches people off guard is the next step up.
If you sailed through the first few weeks, a return of nausea or loose stools at 5mg or beyond can feel like a setback. It is not. Each dose increase essentially resets the adjustment curve: the body needs time to recalibrate to a higher level of GIP and GLP-1 receptor activity. For a detailed look at how quickly side effects begin after each injection at different dose stages, that page goes into the evidence in more depth.
The pattern for most people is that symptoms are stronger in the first one to two weeks at a new dose, then ease as the body acclimatises. Understanding how soon after taking Mounjaro side effects start can help you plan around your injection day, particularly when stepping up to a higher dose. Some people choose to stay at a lower dose for longer rather than titrating on the standard schedule; that is a conversation to have with your prescriber, not a decision to make unilaterally.
Fatigue, headache and dizziness also appear on the side-effect list and tend to follow a similar early-dose pattern. Injection-site reactions (mild redness or tenderness at the injection point) are localised and usually resolve quickly; rotating sites between the abdomen, thigh and upper arm helps.
Most Mounjaro side effects are manageable and short-lived. Some are not, and it matters to know the difference. In January 2026, the MHRA issued a Drug Safety Update drawing attention to acute pancreatitis as a known but infrequent risk with GLP-1 medicines. The symptom to act on is severe stomach pain that does not ease, particularly pain that spreads to the back, with or without vomiting. That is not a side effect to sit out. Stop and seek urgent medical attention.
Other reasons to get help promptly rather than monitoring at home: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing); significant dehydration from persistent vomiting or diarrhoea; gallbladder symptoms such as sharp upper-right abdominal pain with fever or yellowing of the skin. Knowing how long Mounjaro side effects typically last can help you judge whether what you are experiencing is a normal adjustment or something that needs attention sooner. Low mood or thoughts of self-harm, though uncommon, should also prompt a call to your GP or 111 without delay.
You can report any suspected side effect (however mild) using the MHRA Yellow Card scheme. The data genuinely shapes how regulators monitor these medicines over time, so reporting is worthwhile even if you feel it was nothing serious.
Here is something our prescribers hear regularly: people who started Mounjaro elsewhere, without much explanation of what to expect, found the first few weeks genuinely alarming, not because the symptoms were severe, but because nobody had told them the timeline. Many patients find it useful to read up on how soon Mounjaro side effects start before their first injection, so that the experience feels expected rather than alarming.
At nume, a real prescriber reviews your consultation the same day, not an automated decision engine. Part of that process is setting expectations: what the side-effect profile looks like at your starting dose, what changes to watch for as you step up, and what would warrant a conversation versus a trip to A&E. You can read more about our approach to clinical oversight or look at the weight-loss treatments we prescribe if you are still in the research phase.
If you have specific concerns about whether Mounjaro is the right fit given your health history, starting a free consultation is the practical next step, our prescribers discuss suitability and side effects as part of that process, with no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.